Report overview
The global Bioresorbable Coronary Stent market size is estimated to be $408 million in 2023, and will reach $1096 million by 2032, growing at a CAGR of 11.6% during the forecast period from 2024 to 2032.
This report studies the Bioresorbable Coronary Stent market, covering market size for segment by type (Polymer Stents, Metallic Stents, etc.), by application (Hospitals & Clinics, Cardiac Centers, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Abbott Laboratories, BIOTRONIK, Boston Scientific, Medtronic, Elixir Medical, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Bioresorbable Coronary Stent from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Bioresorbable Coronary Stent market.
Leading Players of Bioresorbable Coronary Stent including:
Abbott Laboratories
BIOTRONIK
Boston Scientific
Medtronic
Elixir Medical
Arterius
CORDIS
Kyoto Medical Planning
REVA Medical
Microport Scientific
Meril Life Sciences
Market split by Type:
Polymer Stents
Metallic Stents
Market split by Application:
Hospitals & Clinics
Cardiac Centers
ASC & Others
Market split by Sales Channel:
Direct Channel
Distribution Channel
Market split by Region/Country:
North America (United States and Canada)
Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
South America (Brazil, Mexico, and Argentina, etc.)
Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
